Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 28 Apr 21 424B4 Prospectus supplement with pricing info
- 27 Apr 21 EFFECT Notice of effectiveness
- 26 Apr 21 S-1/A IPO registration (amended)
- 26 Apr 21 S-1/A IPO registration (amended)
- 23 Apr 21 S-1/A IPO registration (amended)
- 9 Apr 21 S-1/A IPO registration (amended)
- 7 Apr 21 S-1/A IPO registration (amended)
-
11 Feb 21 S-1 IPO registration
PTIX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated April 27, 2020 with respect to the audited consolidated financial statements of Protagenic Therapeutics, Inc. for the years ended December 31, 2019 and 2018. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
February 11, 2021